Dana-Farber Cancer Institute, Inc.;達納-法伯癌症研究所股份有限公司
发明人:
QI, Jun,TANAKA, Minoru,ROBERTS, Justin, M.,BRADNER, James E.
申请号：
HK18115879
公开号：
HK1256796A1
申请日:
2018.12.11
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The present invention provides bivalent inhibitors of BET bromodomains, such as compounds of Formulae (I), (II), (III), (IV), (V) and (VI). Some bromdomain-containing proteins (e.g., BRD4) have a tandem bromodomain primary structure comprising more than one bromodomain binding site (e.g., BRD4 comprises BD1 and BD2). Bivalent inhibitors of BET bromodomains provided herein can target bromodomains through advantageous multivalent interactions, and can therefore can be to treat diseases comprising the inventive compounds, as well as methods of using the inventive compounds.
